MRNA
−$457.2K
4,596 sh @ $99
AFEYAN NOUBAR
Director, 10% Owner · SEC CIK 1222012Advertisement
Buy track record
How this insider's open-market purchases have performed8%
of buys now in profit
1 up · 12 down
Avg return since buy−90.8%
Median return−99.9%
Best trade+19.1%
Worst trade−99.9%
Buys scored13
Average return by holding period — separates good entry timing from riding one long winner
After 1 month
+1.0%
8% won · 13 trades
After 3 months
−0.1%
0% won · 13 trades
After 6 months
+0.0%
0% won · 12 trades
After 12 months
+0.0%
0% won · 12 trades
| Date | Company | 90d trend | Buy price | Value | ΔOwn | 1M | 3M | 6M | 12M | To date |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | GENB | $16 | $25M | NEW | +13.0% | −1.6% | — | — | +19.1% | |
| Jan 30, 2013 | BGMD | $2 | $500K | +11% | +0.0% | +0.0% | +0.0% | +0.0% | −99.9% | |
| Jan 30, 2013 | BGMD | $2 | $250K | +24% | +0.0% | +0.0% | +0.0% | +0.0% | −99.9% | |
| Jan 30, 2013 | BGMD | $2 | $150K | +54% | +0.0% | +0.0% | +0.0% | +0.0% | −99.9% | |
| Jan 30, 2013 | BGMD | $2 | $1M | +21% | +0.0% | +0.0% | +0.0% | +0.0% | −99.9% | |
| Jan 30, 2013 | BGMD | $2 | $2.1M | +147% | +0.0% | +0.0% | +0.0% | +0.0% | −99.9% | |
| Feb 9, 2011 | BGMD | $7 | $250K | +7.3% | +0.0% | +0.0% | +0.0% | +0.0% | −99.9% | |
| Feb 9, 2011 | BGMD | $7 | $75K | +3.7% | +0.0% | +0.0% | +0.0% | +0.0% | −99.9% | |
| Feb 9, 2011 | BGMD | $7 | $150K | +30% | +0.0% | +0.0% | +0.0% | +0.0% | −99.9% | |
| Feb 9, 2011 | BGMD | $7 | $100K | +11% | +0.0% | +0.0% | +0.0% | +0.0% | −99.9% | |
| Feb 9, 2011 | BGMD | $7 | $1.9M | +13% | +0.0% | +0.0% | +0.0% | +0.0% | −99.9% | |
| Feb 9, 2011 | BGMD | $7 | $300K | +2.0% | +0.0% | +0.0% | +0.0% | +0.0% | −99.9% | |
| Feb 9, 2011 | BGMD | $7 | $5M | NEW | +0.0% | +0.0% | +0.0% | +0.0% | −99.9% |
How this is calculated. We score only open-market purchases (SEC code
P) — the buys that carry real signal. Each trade's return is measured from the adjusted closing price on the purchase date to the latest close, accounting for stock splits and dividends. The 1M/3M/6M/12M columns show the same trade's return after each fixed holding period; a dash means that horizon hasn't elapsed yet or isn't priceable. Sales are excluded because insiders sell for many routine reasons. With only 13 scored trades, treat this as a small sample, not a verdict.
Advertisement
Open-market buys
$36.78M
13 trades
Open-market sells
$106.91M
166 trades
Net flow
−$70.14M
Net selling
Total filings
183
transactions shown
Full transaction history
All Form 4 activity across every company, newest firstMRNA
−$20K
200 sh @ $100
MRNA
−$479.3K
4,614 sh @ $104
MRNA
−$985.4K
9,380 sh @ $105
MRNA
−$106.4K
1,006 sh @ $106
Advertisement
SANA
−$0
70,813 sh
MRNA
−$463.2K
4,281 sh @ $108
MRNA
−$454K
4,174 sh @ $109
MRNA
−$154.4K
1,400 sh @ $110
MRNA
−$433.2K
3,895 sh @ $111
MRNA
−$101K
900 sh @ $112
MRNA
−$28.3K
250 sh @ $113
MRNA
−$11.4K
100 sh @ $114
MRNA
−$966.6K
9,011 sh @ $107
MRNA
−$614.8K
5,689 sh @ $108
MRNA
−$32.7K
300 sh @ $109
MCRB
−$8.85M
320,562 sh @ $28
MCRB
−$2.21M
80,141 sh @ $28
MCRB
−$16.54M
599,297 sh @ $28
BGMD
−$7.7K
3,390 sh @ $2
BGMD
−$1.2K
530 sh @ $2
BGMD
Afeyan Noubar, BGMD's 10% owner, spent $500K of their own money on 250,000 shares at $2, growing their stake 11%.
+$500K
250,000 sh @ $2
BGMD
Afeyan Noubar, BGMD's 10% owner, spent $250K of their own money on 125,000 shares at $2, growing their stake 24%.
+$250K
125,000 sh @ $2
BGMD
Afeyan Noubar, BGMD's 10% owner, spent $150K of their own money on 75,000 shares at $2, growing their stake 54%.
+$150K
75,000 sh @ $2
BGMD
Afeyan Noubar, BGMD's 10% owner, spent $1M of their own money on 500,000 shares at $2, growing their stake 21%.
+$1M
500,000 sh @ $2
BGMD
Afeyan Noubar, BGMD's 10% owner, spent $2.1M of their own money on 1.05M shares at $2, growing their stake 147%.
+$2.1M
1.05M sh @ $2
BGMD
Afeyan Noubar, BGMD's 10% owner, spent $250K of their own money on 35,715 shares at $7, growing their stake 7%.
+$250K
35,715 sh @ $7
BGMD
Afeyan Noubar, BGMD's 10% owner, spent $75K of their own money on 10,714 shares at $7, growing their stake 4%.
+$75K
10,714 sh @ $7
BGMD
Afeyan Noubar, BGMD's 10% owner, spent $150K of their own money on 21,428 shares at $7, growing their stake 30%.
+$150K
21,428 sh @ $7
BGMD
Afeyan Noubar, BGMD's 10% owner, spent $100K of their own money on 14,285 shares at $7, growing their stake 11%.
+$100K
14,285 sh @ $7
Frequently asked questions
How is AFEYAN NOUBAR's win rate calculated?
We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.
Why are some buys not included in the score?
A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.
What do the 1M / 3M / 6M / 12M columns mean?
They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.
Does a high win rate mean I should copy this insider?
No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.
Where does this data come from?
Trades come from AFEYAN NOUBAR's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.